Adelene Q. Perkins, President & Chief Business Officer at INFINITY PHARMACEUTICALS, INC. (INFI), bought 22,041 shares at $5.70 ($136K) on 2008-11-25, disclosed to the SEC on 2008-11-26.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.87 | 1,180 | $7K | 5.1% |
| 2 | $6.00 | 1,820 | $11K | 8.0% |
| 3 | $6.12 | 5,700 | $35K | 25.7% |
| 4 | $6.19 | 4,300 | $27K | 19.6% |
| 5 | $6.25 | 8,941 | $56K | 41.2% |
| 6 | $5.70 | 100 |
| $570 |
| 0.4% |
| Total | $6.16 avg | 22,041 | $136K | 100% |
| Filing → |
| INFI | SELL | 2018-03-07 | $14K | — | Filing → |
| INFI | SELL | 2015-06-26 | $55K | — | Filing → |
| INFI | SELL | 2015-05-28 | $128K | — | Filing → |